EP Patent

EP1467790A1 — Medicament dispenser

Assigned to Glaxo Group Ltd · Expires 2004-10-20 · 22y expired

What this patent protects

There is provided a medicament dispenser (200)for use in the delivery of a combination medicament product. The dispenser (200) comprises first and second medicament containers (201a, 201b) for containing first and second medicament active component; and first and second release m…

USPTO Abstract

There is provided a medicament dispenser (200)for use in the delivery of a combination medicament product. The dispenser (200) comprises first and second medicament containers (201a, 201b) for containing first and second medicament active component; and first and second release means (216a, 216b) for releasing respective dose portions of the first and second medicament active component from the first and second medicament containers (201a, 201b). The first medicament active component is kept separate from the second medicament active component until the point of release thereof for delivery in combination. The first medicament active component is selected from the group consisting of salmeterol, formoterol and any salts or solvates thereof. The second medicament active component is selected from the group consisting of beclomethasone ester, fluticasone ester and any salts or solvates thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1467790A1
Jurisdiction
EP
Classification
—
Expires
2004-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.